the Third Affiliated Hospital of Kunming Medical College Yunnan Tumor Hospital Kunming

of Kunming, China

the Third Affiliated Hospital of Kunming Medical College Yunnan Tumor Hospital Kunming

of Kunming, China
SEARCH FILTERS
Time filter
Source Type

PubMed | the Third Affiliated Hospital of Kunming Medical College Yunnan Tumor Hospital Kunming, Tianjin Medical University, Chengdu University of Technology and Peking Union Medical College
Type: Journal Article | Journal: Thoracic cancer | Year: 2015

Lung cancer is the leading cause of cancer-related death in China. Results from a randomized controlled trial using annual low-dose computed tomography (LDCT) in specific high-risk groups demonstrated a 20% reduction in lung cancer mortality.A China national lung cancer screening guideline was developed by lung cancer early detection and treatment expert group appointed by the National Health and Family Planning Commission, based on results of the National Lung Screening Trial, systematic review of evidence related to LDCT screening, and protocol of lung cancer screening program conducted in rural China.Annual lung cancer screening with LDCT is recommended for high risk individuals aged 50-74 years who have at least a 20 pack-year smoking history and who currently smoke or have quit within the past five years. Individualized decision making should be conducted before LDCT screening. LDCT screening also represents an opportunity to educate patients as to the health risks of smoking; thus, education should be integrated into the screening process in order to assist smoking cessation.A lung cancer screening guideline is provided for the high-risk population in China.

Loading the Third Affiliated Hospital of Kunming Medical College Yunnan Tumor Hospital Kunming collaborators
Loading the Third Affiliated Hospital of Kunming Medical College Yunnan Tumor Hospital Kunming collaborators